CION Cancer Clinics
New cancers after a liver transplant: the risk and the checks | CION Cancer Clinics
A liver transplant raises the risk of a new cancer elsewhere in the body, mainly because anti-rejection medicines turn the immune system down. Skin cancer and a type of lymphoma are the most common. Most people never develop one, and simple regular checks find many early. This page explains which cancers to watch for, the checks that help and how treatment is planned around the new liver. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
On this page
- Does a liver transplant raise the risk of a new cancer?
- Which new cancers are more likely after a transplant?
- What checks should I have after a liver transplant?
- How is a new cancer different from the liver cancer coming back?
- How is a new cancer treated in someone with a transplanted liver?
- What do families often believe about cancer after a transplant?
- What can this page not tell you?
- Common questions about new cancers after a liver transplant
The short answer
Does a liver transplant raise the risk of a new cancer?
Yes, somewhat. The medicines that stop your body rejecting the new liver also weaken its ability to find and clear abnormal cells, so a new cancer elsewhere in the body is more likely than in someone of the same age who has not had a transplant. Most people never develop one, and regular checks find many of these cancers early.
A new cancer is not the old one coming back
This page is about a different cancer starting somewhere new, such as the skin or the lymph glands. The liver cancer you had transplanted for returning is a separate question, with its own checks, explained on our page on cancer coming back after a transplant. The two are told apart with scans and, usually, a biopsy.
Why the risk exists at all
Your immune system quietly removes damaged cells every day. It also keeps some viruses in check that can, over many years, push cells towards cancer. Anti-rejection medicines turn that watchfulness down. The transplant team balances enough medicine to protect the liver against as little as possible, which is one reason your doses are reviewed over time. You can read more on immunosuppression for life.
A raised risk is not a forecast. It is a reason for regular, simple checks.Where to look
Which new cancers are more likely after a transplant?
The pattern is well known, which is what makes it possible to watch for. Your own risk depends on your age, your history and why you needed the transplant.
Skin cancer
The most common new cancer after any organ transplant. It usually appears on skin that sees the sun, such as the face, ears, neck, scalp and backs of the hands. Most are found early and treated with a small operation.
Post-transplant lymphoma (PTLD)
A cancer of the lymph glands, often linked to the Epstein-Barr virus, a common virus most people carry silently. It can appear as swollen glands, fever, night sweats or weight loss.
Cancers linked to earlier habits
People who smoked or chewed tobacco, or drank heavily before the transplant, carry a higher risk of mouth, throat, food pipe and lung cancer. This is about risk, not blame.
Other cancers
Some cancers linked to viruses, such as cervical cancer, are also more common.
- Bowel cancer, especially with a history of certain bile duct diseases
- Kidney cancer
- Kaposi sarcoma, which is rare
Not sure whether this applies to you?
Ask an oncologistWhat you can do
What checks should I have after a liver transplant?
Look at your own skin
Check your skin once a month in good light, with a family member looking at your back and scalp. Report any spot that is new, growing, bleeding, crusting or not healing. Cover up and use sunscreen in the Hyderabad sun.
A skin examination by a doctor
Ask your transplant team how often a doctor should examine your skin. People with fair skin or earlier skin cancers are usually seen more often.
Keep up ordinary screening
Cervical, breast and bowel screening still apply, and may be advised earlier or more often. Your transplant team will tell you which apply to you and when.
Stop tobacco completely
This includes gutka, khaini and beedis. It is the single biggest change that lowers the risk of mouth, throat and lung cancer after a transplant. Ask for help quitting; it is offered without judgement.
Report the warning signs early
Tell your team about swollen glands, fevers with no clear cause, drenching night sweats, weight loss, a mouth ulcer that does not heal, or blood in your stools.
Side by side
How is a new cancer different from the liver cancer coming back?
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
If one is found
How is a new cancer treated in someone with a transplanted liver?
It is treated as that type of cancer, with one extra person in the room: your transplant doctor. Every decision has to protect the new liver as well as treat the cancer.
Adjusting the anti-rejection medicines
The transplant team often lowers the dose of anti-rejection medicine, or switches to a different kind, so the immune system can help fight the cancer. Some early lymphomas shrink with this change alone. The trade-off is a higher risk of rejection, so blood tests are watched closely.
Choosing cancer treatment carefully
Surgery, chemotherapy and radiation are usually possible. Immunotherapy is a special case, because it can provoke the body into rejecting the new liver. Why it is usually avoided is explained on our page on immunotherapy after a transplant.
Where CION fits
CION's oncologists see people after a transplant for consultations and second opinions, and give chemotherapy and other medicines in step with the transplant team. Scans and biopsies are arranged through accredited partner centres, and the tumour board reviews the results before a plan is confirmed.
Commonly believed
What do families often believe about cancer after a transplant?
Cancer passed on through a donated liver is very rare, because donors are carefully checked. New cancers after a transplant almost always start in your own body.
Never change them yourself. Rejection is a real and immediate danger. Only the transplant team can decide whether a lower dose or a different medicine is right for you.
Darker skin is better protected, but skin cancer can still happen after a transplant, including on the soles, palms and inside the mouth. Checking matters whatever your skin colour.
A new cancer found early is often very treatable. Many people live well after treatment for a skin cancer or an early lymphoma found after a transplant.
Being straight with you
What can this page not tell you?
It cannot tell you your own risk. That depends on your age, your skin, your earlier habits, the virus tests done before your transplant and the medicines you take. Your transplant team knows all of these and can tell you which checks matter most for you.
Who this page does not apply to
If your liver cancer was treated by removing part of your own liver, or with TACE, ablation or tablets, you do not take anti-rejection medicines, and this raised risk does not apply. Your follow-up is about the liver cancer itself, and is explained on our page on follow-up after liver cancer treatment.
It cannot read a spot, a lump or a report
No page can tell you whether a mark on your skin or a swollen gland is cancer. Show it to a doctor rather than waiting to see if it settles, and mention your transplant every time you see someone new.
Questions we are asked
Common questions about new cancers after a liver transplant
Why does a transplant raise the risk of cancer?
Anti-rejection medicines turn down the immune system so it does not attack the new liver. The same immune system normally clears damaged cells and keeps some cancer-linked viruses quiet. With it turned down, a new cancer is more likely, though most people who have had a transplant never develop one.
What is the most common new cancer after a liver transplant?
Skin cancer, usually on skin exposed to the sun. Most skin cancers found early are removed with a small operation. Checking your own skin regularly and having a doctor examine it are the simplest ways to catch one early.
What is PTLD?
Post-transplant lymphoproliferative disorder is a type of lymphoma, a cancer of the lymph glands, that can develop after a transplant. It is often linked to the Epstein-Barr virus. It can cause swollen glands, fever, night sweats or weight loss, and is diagnosed with a biopsy.
Is the risk highest soon after the transplant or later?
It differs by cancer. Lymphoma linked to the Epstein-Barr virus is more common in the first year or two, while skin cancer risk builds up slowly over many years. That is why checks continue for life, not just in the early period.
Can I still have cancer screening tests?
Yes, and you should. Cervical, breast and bowel screening all still apply, and your team may suggest starting earlier or repeating them more often. Tell the person doing the test that you have had a liver transplant.
Will I have to stop my anti-rejection medicines?
Rarely stop completely. More often the dose is lowered or the medicine is changed to another kind, and your liver tests are watched closely. This decision belongs to your transplant team, working together with the oncologist treating the new cancer.
Can I have immunotherapy if I develop a new cancer?
It is usually avoided, because it can trigger rejection of the new liver, which can be severe. In a few situations it may be discussed after careful weighing by both teams. Your oncologist and transplant doctor will explain the alternatives.
Can CION help if a new cancer is found?
Yes. CION's oncologists offer consultations and second opinions, plan treatment through the tumour board, and give chemotherapy and other medicines in step with your transplant team. Call the helpline and the team will tell you what to bring.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- MedlinePlus — Liver Transplantation
- NIDDK — Liver Transplant - NIDDK
- NHS Blood and Transplant — Liver - Organ transplantation - NHS Blood and Transplant
- American Cancer Society — Living as a Liver Cancer Survivor
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Worried about a new symptom after your transplant?
CION's oncologists can review your reports and work with your transplant team on what to check next. One helpline serves every CION centre.